Citigroup Inc Mesoblast LTD Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.48 - $3.48 $2 - $20	6 Added 6.67%	96 $0
Q2 2022 Aug 10, 2022	SELL	$2.22 - $4.54 $694 - $1,421	-313 Reduced 77.67%	90 $0
Q1 2022 May 12, 2022	BUY	$3.58 - $4.98 $1,184 - $1,648	331 Added 459.72%	403 $2,000
Q4 2021 Feb 10, 2022	BUY	$4.17 - $7.09 $300 - $510	72 New	72 $0

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.